Home > Healthcare > Pharmaceuticals > Finished Drug Form > injectable contraceptives market
Get a free sample of Injectable Contraceptives Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Injectable Contraceptives Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The prominent players in injectable contraceptives market are
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Pfizer Inc., Amphastar Pharmaeceutical Inc., Zhejiang xianju Pharmaceutical co., ltd., Eugia pharma, Mylan labs ltd.,Bayer Plc, Teva Pharms USA, PT Tunggal, Incepta Pharmaceuticals, and Baxter International Inc. are some of the major injectable contraceptives companies worldwide.
North America injectable contraceptives market size recorded USD 137.3 million in 2022 and is expected to reach USD 186.9 million by 2032 owing to the well-established healthcare systems and widespread access to variety of contraceptives in the region.
The progesterone-only type segment recorded 68.8% share of the injectable contraceptives industry in 2022 and will witness significant growth from 2023-2032 on account of its high level of efficacy and reliability in preventing unintended pregnancies.
Injectable contraceptives industry size was valued at USD 339.5 million in 2022 and will register 3.5% CAGR from 2023-2032 due to the growing awareness about family planning worldwide.